Reducing Peg-IFN doses causes later virologic response or no response in HCV genotype 1 patients treated with Peg-IFN alfa-2b plus ribavirin

• OZE Tsugiko

  Department of Gastroenterology and Hepatology, Osaka University Graduate School of Medicine

• HIRAMATSU Naoki

  Department of Gastroenterology and Hepatology, Osaka University Graduate School of Medicine

• SONG Changho

  Department of Gastroenterology and Hepatology, Osaka University Graduate School of Medicine

• YAKUSHIJIN Takayuki

  Department of Gastroenterology and Hepatology, Osaka University Graduate School of Medicine

• IIO Sadaharu

  Higashiosaka City Central Hospital

• DOI Yoshinobu

  Otemae Hospital

• OSHITA Masahide

  Osaka Police Hospital

• HAGIWARA Hideki

  Kansai Rosai Hospital

• MITA Eiji

  National Hospital Organization Osaka National Hospital

• ITO Toshifumi

  Osaka Koseinenkin Hospital

• INUI Yoshiaki

  Hyogo Prefectural Nishinomiya Hospital

• HIJIOKA Taizo

  National Hospital Organization Osaka Minami Medical Center

• TAMURA Shinji

  Minoh City Hospital

• YOSHIHARA Harumasa

  Osaka Rosai Hospital

• INOUE Atsuo

  Osaka General Medical Center

• IMAI Yasuharu

  Ikeda Municipal Hospital

• HAYASHI Eijiro

  Kinki Central Hospital of Mutual Aid Association of Public School Teachers

• KATO Michio

  National Hospital Organization Minami Wakayama Medical Center

• MIYAZAKI Masanori

  Department of Gastroenterology and Hepatology, Osaka University Graduate School of Medicine

• HOSUI Atsushi

  Department of Gastroenterology and Hepatology, Osaka University Graduate School of Medicine

• MIYAGI Takuya

  Department of Gastroenterology and Hepatology, Osaka University Graduate School of Medicine

• YOSHIDA Yuichi

  Department of Gastroenterology and Hepatology, Osaka University Graduate School of Medicine

• TATSUMI Tomohide

  Department of Gastroenterology and Hepatology, Osaka University Graduate School of Medicine

• KISO Shinichi

  Department of Gastroenterology and Hepatology, Osaka University Graduate School of Medicine

• KANTO Tatsuya

  Department of Gastroenterology and Hepatology, Osaka University Graduate School of Medicine

• KASAHARA Akinori

  Department of Gastroenterology and Hepatology, Osaka University Graduate School of Medicine

• HAYASHI Norio

  Kansai Rosai Hospital

• TAKEHARA Tetsuo

  Department of Gastroenterology and Hepatology, Osaka University Graduate School of Medicine

収録刊行物

• Journal of gastroenterology

  Journal of gastroenterology 47 (3), 334-342, 2012-03-01

キーワード

• Chronic hepatitis C
• Pegylated interferon plus ribavirin
• Drug adherence
• HCV RNA negativity
• Propensity score matched study

詳細情報

• CRID: 1571698600692892032
• NII論文ID: 10030560255
• NII書誌ID: AA10988015
• ISSN: 09441174
• Web Site: https://search.jamas.or.jp/link/ui/2013106594
• 本文言語コード: en
• データソース種別:
  • CiNii Articles